Satsuki Matsushima
Mitaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Hi-C analysis of amplification of MYC, PVT1, and CCDC26 on marker chromosomes in the NB-4 cell line.
Hi-C analysis of amplification of MYC, PVT1, and CCDC26 on marker chromosomes in the NB-4 cell line.
Journal: Cancer genetics
Published: February 20, 2025
Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?
Journal: Viruses
Published: April 01, 2022
Sonographically Measured Adipose Tissue Thickness Correlates with Laboratory Test Abnormalities Reflecting Metabolic State in Elderly Women.
Journal: Metabolic syndrome and related disorders
Published: December 28, 2021
Discrimination of well-differentiated liposarcoma from benign lipoma on sonography: an uncontrolled retrospective study.
Journal: Journal of medical ultrasonics (2001)
Published: May 11, 2020
Predisposition to Lung Adenocarcinoma in a Family Harboring the Germline EGFR V843I Mutation.
Journal: JCO precision oncology
Published: June 25, 2019
Sonographic Appearances of Liposarcoma: Correlations with Pathologic Subtypes.
Journal: Ultrasound in medicine & biology
Published: October 05, 2018
Relationship between Pericardial Adipose Tissue Thickness and Early Impairment of Left Ventricular Function, Both Evaluated on Echocardiography.
Journal: Rinsho byori. The Japanese journal of clinical pathology
Published: October 01, 2016
KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers.
Journal: Japanese clinical medicine
Published: July 11, 2016
Whole-Genome Sequence of Mycobacterium kyorinense.
Journal: Genome announcements
Published: October 18, 2014
Relationship between epicardial adipose tissue thickness and early impairment of left ventricular systolic function in patients with preserved ejection fraction.
Journal: Heart and vessels
Published: August 20, 2014
V843I, a lung cancer predisposing EGFR mutation, is responsible for resistance to EGFR tyrosine kinase inhibitors.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 25, 2014
Last Updated: 09/26/2026